JP2003535887A5 - - Google Patents

Download PDF

Info

Publication number
JP2003535887A5
JP2003535887A5 JP2002503263A JP2002503263A JP2003535887A5 JP 2003535887 A5 JP2003535887 A5 JP 2003535887A5 JP 2002503263 A JP2002503263 A JP 2002503263A JP 2002503263 A JP2002503263 A JP 2002503263A JP 2003535887 A5 JP2003535887 A5 JP 2003535887A5
Authority
JP
Japan
Prior art keywords
lower alkyl
substituted
phenyl
optionally
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002503263A
Other languages
English (en)
Japanese (ja)
Other versions
JP3886897B2 (ja
JP2003535887A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/006506 external-priority patent/WO2001097786A2/en
Publication of JP2003535887A publication Critical patent/JP2003535887A/ja
Publication of JP2003535887A5 publication Critical patent/JP2003535887A5/ja
Application granted granted Critical
Publication of JP3886897B2 publication Critical patent/JP3886897B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002503263A 2000-06-21 2001-06-08 ベンゾチアゾール誘導体 Expired - Fee Related JP3886897B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00113219 2000-06-21
EP00113219.0 2000-06-21
PCT/EP2001/006506 WO2001097786A2 (en) 2000-06-21 2001-06-08 Benzothiazole derivatives

Publications (3)

Publication Number Publication Date
JP2003535887A JP2003535887A (ja) 2003-12-02
JP2003535887A5 true JP2003535887A5 (enExample) 2006-10-26
JP3886897B2 JP3886897B2 (ja) 2007-02-28

Family

ID=8169041

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002503263A Expired - Fee Related JP3886897B2 (ja) 2000-06-21 2001-06-08 ベンゾチアゾール誘導体

Country Status (33)

Country Link
US (8) US6521754B2 (enExample)
EP (2) EP1303272B1 (enExample)
JP (1) JP3886897B2 (enExample)
KR (2) KR100526487B1 (enExample)
CN (1) CN1234358C (enExample)
AR (1) AR031244A1 (enExample)
AT (1) ATE385794T1 (enExample)
AU (2) AU8181701A (enExample)
BR (1) BR0112395A (enExample)
CA (1) CA2413086C (enExample)
CY (1) CY1107401T1 (enExample)
CZ (1) CZ2003182A3 (enExample)
DE (1) DE60132777T2 (enExample)
DK (1) DK1303272T3 (enExample)
EC (1) ECSP024399A (enExample)
ES (1) ES2299504T3 (enExample)
HR (1) HRP20020962A2 (enExample)
HU (1) HUP0301315A3 (enExample)
IL (2) IL153278A0 (enExample)
JO (1) JO2503B1 (enExample)
MX (1) MXPA02012596A (enExample)
MY (1) MY138352A (enExample)
NO (2) NO324635B1 (enExample)
NZ (1) NZ522928A (enExample)
PE (1) PE20020104A1 (enExample)
PL (1) PL207384B1 (enExample)
PT (1) PT1303272E (enExample)
RU (1) RU2251419C2 (enExample)
SI (1) SI1303272T1 (enExample)
UY (1) UY26782A1 (enExample)
WO (1) WO2001097786A2 (enExample)
YU (1) YU96502A (enExample)
ZA (1) ZA200209730B (enExample)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100526487B1 (ko) * 2000-06-21 2005-11-08 에프. 호프만-라 로슈 아게 벤조티아졸 유도체
US6599901B1 (en) * 2001-11-19 2003-07-29 Hoffman-La Roche Inc. Pyridone substituted benzothiazole derivatives
US6620811B2 (en) * 2001-11-19 2003-09-16 Hoffmann-La Roche Inc. Isonicotin- and nicotinamide derivatives of benzothiazoles
EP1450796B1 (en) * 2001-11-27 2008-04-09 F. Hoffmann-La Roche Ag Benzothiazole derivatives
US6624163B2 (en) 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
US6727247B2 (en) * 2001-12-10 2004-04-27 Hoffman-La Roche Inc. Substituted benzothiazole amide derivatives
ATE420082T1 (de) * 2001-12-12 2009-01-15 Hoffmann La Roche Benzothiophene als adenosinrezeptormodulatoren
US6713499B2 (en) * 2001-12-12 2004-03-30 Hoffman-La Roche Inc. 7-Amino-benzothiazole derivatives
US6734179B2 (en) 2001-12-12 2004-05-11 Hoffmann-La Roche Inc. Benzothiazoles
KR20100056569A (ko) 2002-01-28 2010-05-27 교와 핫꼬 기린 가부시키가이샤 운동성 질환에 걸린 환자의 치료 방법
EP2508204B1 (en) * 2002-06-26 2014-09-24 Ono Pharmaceutical Co., Ltd. Remedies for diseases caused by vascular contraction or dilation
US6958420B2 (en) * 2002-07-19 2005-10-25 Board Of Trustees Of Michigan State University Synthesis of aminoarylboronic esters and substituted anilines from arenes via catalytic C-H activation/borylation/amination and uses thereof
US7338956B2 (en) 2002-08-07 2008-03-04 Sanofi-Aventis Deutschland Gmbh Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
AP2005003319A0 (en) 2002-11-19 2005-06-30 Achillion Pharmaceitucals Inc Substituted aryl thioureas and related compounds; inhibitors of viral replication
AR056615A1 (es) * 2002-12-27 2007-10-17 Kyowa Hakko Kogyo Kk Un metodo de tratamiento de trastornos de la conducta
US7087761B2 (en) * 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
EP1587799B1 (en) 2003-01-13 2008-03-12 F. Hoffmann-La Roche Ag Benzoxazole derivatives and their use as adenosine receptor ligands
US6872833B2 (en) * 2003-04-14 2005-03-29 Hoffmann-La Roche Inc. Adenosine receptor ligands
MXPA05012120A (es) * 2003-05-13 2006-02-08 Hoffmann La Roche 2-imidazo-benzotiazoles como ligandos de receptores de adenosina.
ATE389652T1 (de) * 2003-05-19 2008-04-15 Hoffmann La Roche Benzothiazol-derivate als liganden des adenosinrezeptors
AU2004241720B2 (en) * 2003-05-21 2008-11-06 F. Hoffmann-La Roche Ag Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine A2A receptor
ATE396726T1 (de) * 2003-05-30 2008-06-15 Hoffmann La Roche Benzothiazole derivate und ihre anwendung in der behandlung von adenosine a2a rezeptor vermittelte krankheiten
JP2007506654A (ja) * 2003-06-20 2007-03-22 エフ.ホフマン−ラ ロシュ アーゲー Cb1受容体逆作動物質としての2−アミノベンゾチアゾール類
KR20070007759A (ko) * 2003-07-10 2007-01-16 아칠리온 파르마세우티칼스 인코포레이티드 바이러스 복제 억제제로서 유용한 치환된 아릴티오우레아유도체
ES2327684T3 (es) 2003-07-24 2009-11-02 Euro-Celtique S.A. Compuestos heteroaril-tetrahidropiridilo utiles para el tratamiento o la prevencion del dolor.
JP5036310B2 (ja) 2003-08-06 2012-09-26 セノミックス インコーポレイテッド 新規な風味、風味改質剤、味覚剤、味覚向上剤、旨味および甘味味覚剤、および/またはそれらの向上剤および使用
KR20060058132A (ko) 2003-09-19 2006-05-29 에프. 호프만-라 로슈 아게 아데노신 수용체 리간드로서의 싸이아졸로피리딘 유도체
TW200600492A (en) * 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
EP1753760B1 (en) * 2004-05-24 2008-01-02 F.Hoffmann-La Roche Ag 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
KR100834179B1 (ko) * 2004-05-24 2008-05-30 에프. 호프만-라 로슈 아게 4-하이드록시-4-메틸-피페리딘-1-카복실산(4-메톡시-7-모폴린-4-일-벤조티아졸-2-일)-아마이드
ES2339867T3 (es) * 2004-07-22 2010-05-26 F. Hoffmann-La Roche Ag Derivados de benzotiazol.
EP1773795A1 (en) * 2004-07-22 2007-04-18 F.Hoffmann-La Roche Ag Substituted benzothiazoles
SE0401970D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Novel compounds
EP1812392B1 (en) 2004-11-05 2008-07-09 F.Hoffmann-La Roche Ag Process for preparation of isonicotinic acid derivatives
CN101180299B (zh) 2005-03-23 2010-12-15 弗·哈夫曼-拉罗切有限公司 作为mglur2拮抗剂的乙炔基-吡唑并嘧啶衍生物
TWI370820B (en) 2005-04-27 2012-08-21 Takeda Pharmaceutical Fused heterocyclic compounds
BRPI0616571A2 (pt) 2005-09-27 2011-06-21 Hoffmann La Roche oxadiazolil pirazol-piridiminas como antagonistas de mglur2, processo para sua preparação, composição farmacêutica que os contém e uso dos mesmo
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
WO2007098826A2 (en) * 2006-01-18 2007-09-07 Siena Biotech S.P.A. Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
EP3398452B1 (en) 2006-04-21 2024-10-02 Firmenich Incorporated Comestible compositions comprising high potency savory flavorants
US7429589B2 (en) 2006-04-27 2008-09-30 Hoffmann-La Roche Inc. Mono-nitration of aromatic compounds via nitrate salts
CA2651769C (en) * 2006-05-18 2013-12-17 F. Hoffmann-La Roche Ag Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
GB0612428D0 (en) * 2006-06-22 2006-08-02 Prolysis Ltd Antibacterial agents
US8481544B2 (en) 2006-06-22 2013-07-09 Biota Europe Limited Antibacterial compositions
WO2008077809A1 (en) * 2006-12-22 2008-07-03 F. Hoffmann-La Roche Ag Process for the manufacture of 7-oxa-bicyclo derivatives
JP5606075B2 (ja) * 2007-02-14 2014-10-15 ビーエーエスエフ ソシエタス・ヨーロピア エレクトロルミネッセンス金属錯体
UY31050A1 (es) 2007-04-27 2008-07-03 Shionogi & Co Antagonistas de trpv1 y usos de los mismos
US20090082341A1 (en) * 2007-07-23 2009-03-26 Synosia Therapeutics 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide FOR THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER
US7913765B2 (en) * 2007-10-19 2011-03-29 Baker Hughes Incorporated Water absorbing or dissolving materials used as an in-flow control device and method of use
GB0724342D0 (en) 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
JO3101B1 (ar) 2008-12-02 2017-09-20 Takeda Pharmaceuticals Co مشتقات بنزوثيازول كعوامل مضادة للسرطان
KR101064258B1 (ko) * 2008-12-29 2011-09-14 한국과학기술연구원 벤조아릴우레이도 화합물, 및 이를 함유하는 퇴행성 뇌질환예방 또는 치료용 조성물
US8168785B2 (en) 2009-06-17 2012-05-01 Biotie Therapies, Inc. Benzothiazole derivatives
WO2010150927A1 (en) * 2009-06-25 2010-12-29 Sk Holdings Co., Ltd. Pharmaceutical composition for prevention and treatment of cancer diseases comprising benzamide derivatives
RU2455293C2 (ru) * 2010-09-15 2012-07-10 Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО ПГФА Росздрава) N-(2-бензотиазолил)амид 3-бром-2,4-диоксо-4-(4-метоксифенил)бутановой кислоты, обладающий гипогликемической активностью
RU2448100C1 (ru) * 2010-09-24 2012-04-20 Татьяна Николаевна Иванова Производные 2-аминобензотиазола, обладающие противогипоксической активностью, и способ их использования
JP5769326B2 (ja) * 2010-10-19 2015-08-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Rhoキナーゼ阻害薬
DE102011005232A1 (de) 2011-03-08 2012-09-13 AristoCon GmbH & Co. KG Adenosin und seine Derivate zur Verwendung in der Schmerztherapie
WO2012176061A1 (en) 2011-06-22 2012-12-27 Purdue Pharma L.P. Trpv1 antagonists including dihydroxy substituent and uses thereof
TWI571466B (zh) * 2011-10-14 2017-02-21 艾伯維有限公司 用於治療癌症及免疫與自體免疫疾病之細胞凋亡誘發劑
CN103772376B (zh) * 2012-10-24 2017-01-11 中国医学科学院医药生物技术研究所 取代的苯并-1,3-杂唑类化合物、其制备方法及用途
AU2015301891B2 (en) 2014-08-11 2019-12-05 Angion Biomedica Corporation Cytochrome P450 inhibitors and uses thereof
EP3240778A4 (en) * 2014-12-31 2018-07-11 Angion Biomedica Corp. Methods and agents for treating disease
WO2017066225A1 (en) * 2015-10-14 2017-04-20 Texas Tech University System Pharmacoperones of the v2 receptor
ES2978159T3 (es) 2016-09-16 2024-09-06 Hsf Pharmaceuticals Inhibidores de factores de choque térmico (HSF) y usos de los mismos
PL3661941T3 (pl) * 2017-08-01 2023-05-08 Merck Patent Gmbh Pochodne tiazolopirydynowe jako antagoniści receptora adenozynowego
CA3077267C (en) * 2017-09-28 2021-02-16 Cstone Pharmaceuticals (Suzhou) Co., Ltd. Fused heteroaryl ring derivatives useful as a2a receptor inhibitor
AR117844A1 (es) * 2019-01-22 2021-09-01 Merck Patent Gmbh Derivados de tiazolopiridina como antagonistas del receptor de adenosina
DE102019110904B4 (de) * 2019-04-26 2022-01-20 Helmholtz-Zentrum Dresden - Rossendorf E. V. N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung
KR102796857B1 (ko) * 2019-10-08 2025-04-15 현대자동차주식회사 냉각장치와 냉각시스템 및 냉각시스템의 제어방법
EP4077320A4 (en) * 2019-12-16 2024-01-03 The University of British Columbia ANTIVIRAL COMPOUNDS, COMPOSITIONS AND METHODS OF USE
WO2021247921A1 (en) * 2020-06-03 2021-12-09 Yumanity Therapeutics, Inc. Benzothiazole compounds and uses thereof
AU2022214582C1 (en) * 2021-01-29 2025-02-27 Korea Research Institute Of Chemical Technology Benzothiazole and benzimidazole derivatives, pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition comprising same as active ingredient

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505543A (de) * 1968-11-01 1971-04-15 Ciba Geigy Ag Schädlingsbekämpfungsmittel
GB1318291A (en) * 1970-04-15 1973-05-23 Shell Int Research Carboxamide derivatives and fungicidal compositions containing them
NL7109150A (enExample) * 1970-07-06 1972-01-10
JPS5516147B2 (enExample) * 1971-12-24 1980-04-30
US4028374A (en) * 1975-11-03 1977-06-07 Morton-Norwich Products, Inc. Antibacterial thiocyanatobenzothiazoles
DE2656468A1 (de) * 1976-12-14 1978-06-15 Boehringer Mannheim Gmbh N-(benzthiazol-2-yl)-oxamidsaeure- derivate und verfahren zu ihrer herstellung
US4471957A (en) * 1979-12-03 1984-09-18 Baltimore Therapeutic Equipment Company Method and apparatus for rehabilitation of damaged limbs
CA1153867A (en) 1980-05-16 1983-09-20 Michael A. M. Boersma Process for the preparation of crystalline silicates, crystalline silicates so prepared and process for carrying out catalytic reactions
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
FI91859C (fi) 1987-06-17 1994-08-25 Eisai Co Ltd Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
EP0300688A1 (en) * 1987-07-21 1989-01-25 FISONS plc Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
US5348519A (en) * 1988-02-04 1994-09-20 Loredan Biomedical, Inc. Exercise and diagnostic apparatus and method
IL90337A0 (en) * 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
JPH0667923B2 (ja) 1989-05-11 1994-08-31 東洋紡績株式会社 新規なベンゾチアゾール誘導体
WO1990015801A1 (en) * 1989-06-22 1990-12-27 Pfizer Inc. Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases
DE59005183D1 (de) 1989-11-10 1994-05-05 Agrolinz Agrarchemikalien Verfahren zur Herstellung reiner, unsymmetrisch disubstituierter Harnstoffe.
US5142910A (en) * 1990-06-27 1992-09-01 Occupational Orthopaedic Systems, Inc. Dynamic physiological function testing apparatus and method
WO1992006954A2 (en) * 1990-10-15 1992-04-30 Pfizer Inc. Pyrrolidine dione derivatives
US5275045A (en) * 1991-03-07 1994-01-04 Isotechnologies, Inc. Apparatus and method for use in assessing the lifting capability of a human subject
JP2599665B2 (ja) * 1991-05-01 1997-04-09 大塚製薬株式会社 ピラジン誘導体
KR0185225B1 (ko) * 1992-05-21 1999-05-15 오오쓰까 아끼히꼬 포스폰산 디에스테르 유도체
US5312107A (en) * 1993-05-13 1994-05-17 Kordun, Ltd. Golf club swing training and exercise device
JPH0725858A (ja) * 1993-07-13 1995-01-27 Otsuka Pharmaceut Co Ltd ピペラジン誘導体
JPH0940646A (ja) * 1995-07-27 1997-02-10 Yamanouchi Pharmaceut Co Ltd ベンゼン縮合環誘導体又はその塩
FR2753970B1 (fr) * 1996-10-01 1998-10-30 Synthelabo Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
JPH11130761A (ja) * 1997-10-24 1999-05-18 Otsuka Pharmaceut Co Ltd ベンゾチアゾール誘導体
ES2256969T3 (es) * 1997-11-10 2006-07-16 Bristol-Myers Squibb Company Compuestos de benzotiazol inhibidores de proteina tirosina qauinasa.
WO1999031096A1 (en) * 1997-12-18 1999-06-24 Shaman Pharmaceuticals, Inc. Piperazine derivatives useful as hypoglycemic agents
CN1288462A (zh) * 1998-01-23 2001-03-21 法玛西雅厄普约翰美国公司 噁唑烷酮组合库、组合物和制备方法
HK1038749A1 (zh) 1998-09-30 2002-03-28 纽罗根公司 2-哌嗪烷基氨苯并吡咯衍生物:多巴胺受体亚型特异配体
UA71587C2 (uk) * 1998-11-10 2004-12-15 Шерінг Акцієнгезелльшафт Аміди антранілової кислоти та їхнє застосування як лікарських засобів
AU2364600A (en) * 1998-12-23 2000-07-31 Eli Lilly And Company Heteroroaromatic amides as inhibitor of factor xa
IL133680A0 (en) * 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
JP2003534239A (ja) * 1999-12-17 2003-11-18 ヴァージコア・インコーポレーテッド 新規なスクシナート化合物、組成物、並びに使用及び調製方法
KR100526487B1 (ko) * 2000-06-21 2005-11-08 에프. 호프만-라 로슈 아게 벤조티아졸 유도체
US6620811B2 (en) * 2001-11-19 2003-09-16 Hoffmann-La Roche Inc. Isonicotin- and nicotinamide derivatives of benzothiazoles
US6727247B2 (en) * 2001-12-10 2004-04-27 Hoffman-La Roche Inc. Substituted benzothiazole amide derivatives

Similar Documents

Publication Publication Date Title
JP2003535887A5 (enExample)
CN1902196B (zh) 噻唑衍生物
JP5225857B2 (ja) ヘッジホッグシグナル伝達のビスアミド阻害剤
CA2413086A1 (en) Benzothiazole derivatives
EP1971583B1 (en) N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
AU2015239886B2 (en) Indole derivatives for use in medicine
JP2004525965A5 (enExample)
JP2016512825A5 (enExample)
JP2010529991A5 (enExample)
JPWO2022256806A5 (enExample)
JP2010540452A5 (enExample)
JP2006523234A5 (enExample)
JP2006513265A5 (enExample)
JP2009524589A5 (ja) 置換されたイソキノリン−1,3(2h,4h)−ジオン、1−チオキソ−1,4−ジヒドロ−2h−イソキノリン−3−オン、および1,4−ジヒドロ−3(2h)−イソキノロン、ならびにキナーゼインヒビターとしてのそれらの使用
RU2003100518A (ru) Производные бензотиазола
JP2006513202A5 (enExample)
RU2013133800A (ru) Селективные к bcl-2 агенты, вызывающие апоптоз, для лечения рака и иммунных заболеваний
JP2004536066A5 (enExample)
JP2018520096A5 (enExample)
JP2005523901A5 (enExample)
JP2010536846A (ja) 細胞壊死阻害剤としてのインドール及びインダゾール化合物
JP2006500348A5 (enExample)
CN1152870A (zh) 杂环化合物作为多巴胺d3配位体的用途
RU2010118018A (ru) Хиральные цис-имидазолины
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ